Financials
- Market Capitalization 21.09 M
- Employee 12
- Founded 2011
- CEO N/A
- Website www.skyebioscience.com
- Headquarter Nevada, United States
- FIGI BBG00433GZN1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.53
Relación precio/flujo de caja
82.43
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4604 | ALGS Aligos Therapeutics, Inc. - Common stock | 6.17 USD | -2.99% | -0.64% | +16.42% | -36.98% | 21.37 M USD | ||
| 4608 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 5.05 USD | +1.00% | -8.51% | -51.54% | +300.79% | 21.15 M USD | ||
| 4628 | ICU SeaStar Medical Holding Corporation - Common Stock | 5.01 USD | +4.59% | -3.84% | +61.61% | +103.66% | 20.02 M USD | ||
| 4633 | LGVN Longeveron Inc. - Class A Common stock | 0.63 USD | 0.00% | -3.08% | -23.17% | +10.27% | 19.62 M USD |